Skip to main content
OpenTrials
Completed

NCT Number: NCT00584220

Evaluation of Two Toric Soft Contact Lenses After Two Weeks of Wear

The purpose of this study is to determine the relative performance of a new toric soft contact lens against a toric contact lens currently available in market, specifically with regards to the comfort and vision after two weeks of use.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–39 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

Dispensing, single-masked (subject-masked), randomized, 2-visit controlled study of two-weeks duration.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Prior to being considered eligible to participate in this study, subjects MUST

  • be at least 18 and less than or equal to 39 years of age and have a need for vision correction in BOTH eyes (monovision or uniocular fitting is NOT allowed).
  • be of Asian descent (Japanese, Chinese, Korean, Polynesian or other Asian ancestry) and have Asian Eye anatomy.
  • have successfully worn toric or spherical soft (hydrogel or silicone hydrogel) contact lenses for at least 4-weeks prior to enrollment in the study.
  • be able and willing to adhere to the instructions set forth in the protocol.
  • agree to wear their contact lenses in both eyes on a daily wear schedule for at least 8 hours per day every day during the study.
  • have a distance spherical component between -1.00 D and -5.50 D with cylinder in the range of 0.75 D to 2.25 D and cylinder axis within 10 ° of the vertical and within 20 ° of the horizontal in both eyes
  • have a best corrected manifest refraction visual acuity of at least 20/25 or better in each eye.
  • be in good general health, based on his/her knowledge.
  • read, be given an explanation of, indicate understanding of, and sign the STATEMENT OF INFORMED CONSENT.

Exclusion criteria

  • The subject is a rigid gas permeable (RGP) or daily disposable soft lens wearer.
  • The presence of clinically significant (grade 3 or 4) anterior segment abnormalities; inflammations such as iritis; or any infection of the eye, lids, or associated structures.
  • The presence of ocular or systemic disease or need for medication which might interfere with contact lens wear or which would cause the lenses to be removed more than twice a day. (i.e., Sjögren's syndrome, type II diabetes, etc).
  • Slit lamp findings that would contraindicate contact lens wear such as:
  • Pathological dry eye or associated findings
  • Pterygium or corneal scars within the visual axis
  • Neovascularization >1mm in from the limbus
  • History of giant papillary conjunctivitis (GPC) worse than Grade 2
  • Anterior uveitis or iritis (past or present)
  • Seborrhoeic eczema, seborrhoeic conjunctivitis
  • A history of recurrent erosions, corneal infiltrates, corneal ulcer or fungal infections.
  • A known history of corneal hypoesthesia (reduced corneal sensitivity.)
  • Aphakia, keratoconus or a highly irregular cornea.
  • Current pregnancy or lactation (to the best of the subject's knowledge).
  • Active participation in another clinical study at any time during this study.

Treatment and study plan

senofilcon A toric

Device

contact lens

alphafilcon A toric

Device

contact lens

Other names: SofLens66 Toric

Primary outcomes

  1. Subjective Reported Vision

    Time frame: 1 week

    A weighted combined score of one week and two week data calculated from individual vision-related questions asked on a 1-5 scale, 1 = most negative response to 5 = most positive, was used to derive vision outcomes. The analysis shows the outcome for both senofilcon A and alphafilcon A. If score >0 then greater vision, if <0 then lesser vision.

  2. Subject Reported Lens Comfort.

    Time frame: 1 week

    A weighted combined score of one week and two week data calculated from individual comfort-related questions asked on a 1-5 scale, 1=most negative response to 5=most positive response, was used to derive comfort outcomes. The analysis shows the estimates for senofilcon A and alphafilcon A, respectively. Interpretation is >0 indicates comfortable and <0 indicates uncomfortable.

Sponsors and collaborators

Lead sponsor

Johnson & Johnson Vision Care, Inc.

Industry

Collaborators

  • Foresight Regulatory Strategies, Inc.

Registry information

Official study title

Evaluation of Fit and Visual Acuity of the Investigational Toric Lens in Two Phases: Part B: A Dispensing Cross-over Comparison to SofLens66 Toric

Important dates

Study start
2007
Primary completion
2007
Study completion
2007
First posted
Jan 2, 2008
Registry last updated
May 21, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.